Perrigo Company plc
Health
Performance
8.3
Risk
Sell
Buy
Curious about the Scores? Learn more.

Perrigo Company plc stock rating and score history

All changes in ratings, performance and outlook tracked over time.

06.11.2025
Red alert. Risk levels out of control.
31.10.2025
Rock bottom. The fall’s complete, stability nowhere to be found.
20.08.2025
Pulse detected. Still fragile, but stabilizing.

Perrigo Company plc stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Perrigo Company plc do? Business model and key facts

Get the full picture of Perrigo Company plc: what it builds, where it operates, and how it makes money.

Perrigo Company plc Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 8379

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

shop
Company facts
Patrick Lockwood-Taylor
CEO
8379
Employees worldwide
shop
Performance
-44.33%
Last 12 months
-68.26%
Last 5 years
shop
Growth
$4,37B
Revenue year
$-171.800.000
Net income
shop
Valuation
$1,93B
Market Cap
-20.56
Price/Earnings Ratio

Stocks related to Perrigo Company plc

Selected based on industry alignment and relative market positioning.

AVDL
Avadel Pharmaceuticals plc
21.56
-0.05%
7.4
Sell
Buy
Avadel Pharmaceuticals plc
BHC
Bausch Health Companies Inc.
5.72
-1.38%
6.6
Sell
Buy
Bausch Health Companies Inc.
HCM
HUTCHMED (China) Limited
15.24
-2.12%
4.6
Sell
Buy
HUTCHMED (China) Limited
DVAX
Dynavax Technologies Corporation
15.48
-0.26%
7.0
Sell
Buy
Dynavax Technologies Corporation
ANIP
ANI Pharmaceuticals, Inc.
80.45
-1.08%
6.5
Sell
Buy
ANI Pharmaceuticals, Inc.

Perrigo Company plc fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.